DUBAI, United Arab Emirates, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The Global Atopic Dermatitis Treatment Market was valued at US$ 5.2 Bn in 2021 and is expected to reach US$ 7.6 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey. A new market research report by Future Market Insights on the atopic dermatitis treatment market includes global industry analysis 2014–2021 and opportunity assessment 2022–2029.
The report investigates the atopic dermatitis treatment market and provides critical insights for the forecast period of 2022-2029. As per the findings of the report, the global Atopic Dermatitis Treatment Market is projected to experience significant growth over the forecast period, due to increasing prevalence, promising pipeline molecules, higher treatment compliance, increasing access to treatment medication in developing countries, favorable reimbursement policies, increasing government support for research and development, and advancing technology.
Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-3097
| Data Points | Market Insights |
| Market Value 2021 | USD 5.2 Bn |
| Market Value 2029 | USD 7.6 Bn |
| CAGR 2022-2029 | 4.8% |
| Share of Top 5 Countries | 52.1% |
The global atopic dermatitis treatment market was valued ~ US$ 5.2 Bn in 2021, and is expected to increase at a CAGR of 4.8% during the forecast period of 2022 and 2029.
Corticosteroids Remain the Drug of Choice
Corticosteroids are referred as the first choice of treatment for the inflammation and pain relief. These medications are known to have effects, for example, decreasing tingling, allergic reaction, swelling and redness.
Around 30 corticosteroid compounds have been licensed for atopic dermatitis treatment, of which ‘hydrocortisone’ is considered as the first. In addition, increasing innovations have resulted in the advent of topical non-corticosteroids immunomodulators and target medications, for example, immunomodulators such as pimecrolimus and tacrolimus, which in turn, is likely to fuel the growth of the atopic dermatitis treatment market. Moreover, topical corticosteroids are expected to play an important roles in the atopic dermatitis treatment.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-3097
Scope of the Report
| Attribute | Details |
| Forecast Period | 2022-2029 |
| Historical Data Available for | 2014-2021 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa |
| Key Countries Covered | US, Canada, Brazil, Mexico, Poland, Russia, France, U.K., Germany, Spain, Italy, BENELUX, Nordic, China, India, Australia and New Zealand, ASEAN, GCC Countries, Turkey, North Africa and South Africa |
| Key Segments Covered | Drugs, Mode of Administration, Distribution Channel and Region |
| Key Companies Profiled | • Sanofi SA • Galderma SA • Allergan Plc. • Novartis • Bristol-Myers Squibb • Bayer AG • Meda Pharmaceuticals • Astellas Pharma Inc. • Anacor Pharmaceutical Inc. • Regeneron Pharmaceuticals • Valeant Pharmaceutical International Inc. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
North America to Offer High Sales Opportunities
Growth prospects of the atopic dermatitis treatment market are likely to be high in North America over the forecast period of 2022-2029. Factors such as, greater treatment awareness among the patient population across the United States and Canada, early adoption of novel prescriptions, advanced healthcare infrastructure, better and favorable reimbursement policies, and increasing business associations of pharmaceutical organizations with contract research organizations in developing markets will continue to propel the atopic dermatitis treatment market growth.
Despite the fact that the U.S and Canada deal with heavy investment in healthcare infrastructure as well as per capita expenditure, there are increasing number of campaigns organized each year by specific establishments, for example, National Eczema Associations, the PAN Foundation, and pharmaceutical organizations, which are envisaged to work to the advantage of several market vendors.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-3097
Hospital Pharmacies - The Key Distribution Channel for Atopic Dermatitis Treatment
Sales of medication for atopic dermatitis treatment through hospital pharmacies will continue to account for relatively high share in the market, as they can stock large range of prescription medicines, including progressively specific and investigational medications. Hospital pharmacies may provide a tremendous amount of medications every day, which is distributed to wards and to intensive care units as per the patient's prescription schedule.
Topical Drug Administration- A Preferred Mode
Topical mode of administration remains highly preferred among the patient pool of atopic dermatitis. Advent of topical non-corticosteroids immunomodulators is the major factor for the growth in the demand for atopic dermatitis treatment. As topical administration gains prominence, major corticosteroids medications are formulated as topical, in addition to their benefits over oral dosage form.
Buy Now@ https://www.futuremarketinsights.com/checkout/3097
Atopic Dermatitis Treatment Market: Vendor Insights
The report highlights some of the prominent market players, who have established themselves as leaders in the global atopic dermatitis treatment market. Some of the examples of key players in the global atopic dermatitis treatment market are Sanofi S.A., Galderma S.A., Allergan Plc., Novartis, Bristol-Myers Squibb, Bayer AG, Meda Pharmaceuticals Inc., Astellas Pharma, Inc., Anacor Pharmaceuticals, Inc., Regeneron Pharmaceuticals, and Valeant Pharmaceuticals International, Inc.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Traumatic Brain Injuries Treatment Market - Each year traumatic brain injuries (TBI) contribute a substantial number of cases worldwide. TBI can be defined as an injury to the brain resulting from externally inflicted trauma resulting in damage to the brain cells and blood vessels.
Allergy Treatment Market - An allergy is a heightened sensitivity of immune system. Allergy occurs when a foreign substance which is harmless in nature reacts with immune system. These foreign substances are called allergens.
Substance Use Disorder Treatment Market - According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment.
Kids Sports Injury Treatment Market - The primary factor for the growth of global kids’ sports injury market is growing accidents during practice or during performance as the number of children participants in sport activities increases every year from all the age groups.
Schizophrenia Treatment Market - The schizophrenia treatment market is primarily driven by increased prevalence of schizophrenic disorders due to change in lifestyle, extensive R&D, increase in incidence of various addictions such as alcohol, narcotics and others.
Hepatocellular Carcinoma HCC Treatment Market - global hepatocellular carcinoma treatment market. However, side effects associated with the chemotherapy, high cost of treatment are some of the major restraints limiting the growth of global hepatocellular carcinoma treatment market.
Glioblastoma Treatment Drugs Market - Brain tumors is one of the leading cause of cancer which is common among children and teenagers. Glioblastoma (GBM) is most common grade four tumor, is malignant and contains dead tumor cells.
Brain Tumor Treatment Market - A brain tumor is an abnormal and uncontrolled proliferation of cells in the brain. It can be benign or malignant. Brain tumor arises from brain tissue and rarely spreads.
Carcinoid Syndrome Diarrhea Treatment Market - Carcinoid syndrome diarrhea treatment market would grow during the forecast years as many multi-national companies are focusing towards new product innovations in carcinoid syndrome diarrhea treatment.
Radioimmunotherapy Treatment Market - According to Word Health Organization, it is estimated that by 2030, about 23.6 million new cases of cancer will prevail worldwide. Governmental guidelines from American Society of Clinical Oncology and National Comprehensive Cancer Network (NCCN /ASCO) are providing help to healthcare professionals in the management and treatment of cancer patients.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/atopic-dermatitis-treatment-market
Press Release Source: https://www.futuremarketinsights.com/press-release/atopic-dermatitis-treatment-market
